Signia Therapeutics is an innovative French start-up company.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Villeurbanne
State: Rhone-Alpes
Zip:
Country: France
Signia Therapeutics proposes a breakthrough strategy to identify and repurpose rapidly, efficiently and at low cost already marketed drugs or to recycle unused drugs for new antiviral indication against several human respiratory viruses. These antiviral candidates could be directly evaluated in phase II clinical trials and/or quickly available in response to any widespread outbreak for which the medical community and patients have limited options.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2021 | Series A | 1 | $1.5M |
Neovacs Neovacs |
1/2022 | Grant | 1 | $1.9M |
Bpifrance Bpifrance |
8/2018 | Grant | 1 | $83.3k |
EASME - EU Executive Agency for SMEs EASME - EU Executive Agency for SMEs |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|